Institute of Chemical Biology and Fundamental Medicine, Siberian Division of Russian Academy of Sciences, Novosibirsk, 630090, Russia.
Biochemistry (Mosc). 2009 Sep;74(9):945-61. doi: 10.1134/s0006297909090028.
The detection of catalytic activity of antibodies is the earliest indicator of development of autoimmune diseases (AID). In early stages of AID, the repertoire of abzymes with various properties is relatively small, but it is greatly increased during their development. Catalytic diversity of the abzymes includes DNase, RNase, ATPase, and oxidoreductase activities; there are antibodies phosphorylating proteins, lipids, and polysaccharides. This review summarizes new data on abzyme heterogeneity and possible reasons for this phenomenon. A possible role of abzymes and their exceptional multiplicity in the pathogenesis of different AID is discussed.
抗体催化活性的检测是自身免疫性疾病(AID)发展的最早指标。在 AID 的早期阶段,具有各种特性的 abzyme 库相对较小,但在其发展过程中会大大增加。abzyme 的催化多样性包括 DNA 酶、RNA 酶、ATP 酶和氧化还原酶活性;有抗体磷酸化蛋白质、脂质和多糖。本文综述了 abzyme 异质性的新数据及其可能的原因。讨论了 abzyme 及其在不同 AID 发病机制中的异常多样性的可能作用。